UniProt ID | ARH_HUMAN | |
---|---|---|
UniProt AC | Q5SW96 | |
Protein Name | Low density lipoprotein receptor adapter protein 1 {ECO:0000305} | |
Gene Name | LDLRAP1 {ECO:0000312|HGNC:HGNC:18640} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 308 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Adapter protein (clathrin-associated sorting protein (CLASP)) required for efficient endocytosis of the LDL receptor (LDLR) in polarized cells such as hepatocytes and lymphocytes, but not in non-polarized cells (fibroblasts). May be required for LDL binding and internalization but not for receptor clustering in coated pits. May facilitate the endocytocis of LDLR and LDLR-LDL complexes from coated pits by stabilizing the interaction between the receptor and the structural components of the pits. May also be involved in the internalization of other LDLR family members. Binds to phosphoinositides, which regulate clathrin bud assembly at the cell surface. Required for trafficking of LRP2 to the endocytic recycling compartment which is necessary for LRP2 proteolysis, releasing a tail fragment which translocates to the nucleus and mediates transcriptional repression (By similarity).. | |
Protein Sequence | MDALKSAGRALIRSPSLAKQSWGGGGRHRKLPENWTDTRETLLEGMLFSLKYLGMTLVEQPKGEELSAAAIKRIVATAKASGKKLQKVTLKVSPRGIILTDNLTNQLIENVSIYRISYCTADKMHDKVFAYIAQSQHNQSLECHAFLCTKRKMAQAVTLTVAQAFKVAFEFWQVSKEEKEKRDKASQEGGDVLGARQDCTPSLKSLVATGNLLDLEETAKAPLSTVSANTTNMDEVPRPQALSGSSVVWELDDGLDEAFSRLAQSRTNPQVLDTGLTAQDMHYAQCLSPVDWDKPDSSGTEQDDLFSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDALKSAG -------CHHHHHHH | 6.49 | 22814378 | |
5 | Methylation | ---MDALKSAGRALI ---CHHHHHHHHHHH | 39.72 | 115972471 | |
5 | Ubiquitination | ---MDALKSAGRALI ---CHHHHHHHHHHH | 39.72 | - | |
14 | Phosphorylation | AGRALIRSPSLAKQS HHHHHHCCHHHHCCC | 16.31 | 29255136 | |
16 | Phosphorylation | RALIRSPSLAKQSWG HHHHCCHHHHCCCCC | 42.05 | 29255136 | |
19 | Ubiquitination | IRSPSLAKQSWGGGG HCCHHHHCCCCCCCC | 50.59 | - | |
49 | Phosphorylation | LLEGMLFSLKYLGMT HHHHHHHHHHHHCCE | 21.71 | 24719451 | |
67 | Phosphorylation | QPKGEELSAAAIKRI CCCCHHCCHHHHHHH | 21.09 | - | |
72 | Ubiquitination | ELSAAAIKRIVATAK HCCHHHHHHHHHHHH | 31.20 | - | |
79 | Ubiquitination | KRIVATAKASGKKLQ HHHHHHHHHCCCCEE | 38.44 | - | |
81 | Phosphorylation | IVATAKASGKKLQKV HHHHHHHCCCCEEEE | 50.90 | 30576142 | |
93 | Phosphorylation | QKVTLKVSPRGIILT EEEEEEECCCEEEEE | 13.80 | 23917254 | |
184 | Ubiquitination | EEKEKRDKASQEGGD HHHHHHHHHHHHCCC | 54.71 | 21906983 | |
186 | Phosphorylation | KEKRDKASQEGGDVL HHHHHHHHHHCCCCC | 34.21 | 17525332 | |
202 | Phosphorylation | ARQDCTPSLKSLVAT CCCCCCHHHHHHHHH | 30.21 | - | |
205 | Phosphorylation | DCTPSLKSLVATGNL CCCHHHHHHHHHCCC | 33.11 | 28348404 | |
274 | Phosphorylation | TNPQVLDTGLTAQDM CCCCHHCCCCCHHHC | 29.90 | - | |
277 | Phosphorylation | QVLDTGLTAQDMHYA CHHCCCCCHHHCCHH | 24.50 | 27251275 | |
283 | Phosphorylation | LTAQDMHYAQCLSPV CCHHHCCHHHHCCCC | 7.54 | 27642862 | |
288 | Phosphorylation | MHYAQCLSPVDWDKP CCHHHHCCCCCCCCC | 30.42 | 26074081 | |
297 | Phosphorylation | VDWDKPDSSGTEQDD CCCCCCCCCCCCCCC | 38.91 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ARH_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARH_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARH_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LRP2_HUMAN | LRP2 | physical | 14528014 | |
CLH1_HUMAN | CLTC | physical | 12221107 | |
AP2B1_HUMAN | AP2B1 | physical | 12221107 | |
LDLR_HUMAN | LDLR | physical | 12221107 | |
KLC1_HUMAN | KLC1 | physical | 21915095 | |
STN1_HUMAN | OBFC1 | physical | 25416956 | |
NEUL_HUMAN | NLN | physical | 26186194 | |
CHK1_HUMAN | CHEK1 | physical | 26186194 | |
CC85C_HUMAN | CCDC85C | physical | 26186194 | |
DCA16_HUMAN | DCAF16 | physical | 26186194 | |
NEUL_HUMAN | NLN | physical | 28514442 | |
CC85C_HUMAN | CCDC85C | physical | 28514442 | |
CHK1_HUMAN | CHEK1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
603813 | Hypercholesterolemia, autosomal recessive (ARH) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND MASSSPECTROMETRY. |